Literature DB >> 16210569

Smoking, endothelial function, and Rho-kinase in humans.

Kensuke Noma1, Chikara Goto, Kenji Nishioka, Keiko Hara, Masashi Kimura, Takashi Umemura, Daisuke Jitsuiki, Keigo Nakagawa, Tetsuya Oshima, Kazuaki Chayama, Masao Yoshizumi, Yukihito Higashi.   

Abstract

OBJECTIVE: Smoking is associated with endothelial dysfunction and activated Rho-kinase in vascular smooth muscle cells (VSMCs) in humans. The purpose of this study was to elucidate the relationship between endothelial function and Rho-kinase activity in forearm VSMCs in healthy young men. METHODS AND
RESULTS: We evaluated the forearm blood flow (FBF) responses to acetylcholine (ACh), fasudil, a Rho-kinase inhibitor, and sodium nitroprusside (SNP) in male smokers (n=10) and nonsmokers (n=14). FBF was measured by using a strain-gauge plethysmography. The vasodilatory effect of ACh was significantly smaller in smokers than that in nonsmokers. The vasodilatory effect of fasudil was significantly greater in smokers than that in nonsmokers. The vasodilatory effects of SNP in the 2 groups were similar. There was a significant correlation between the maximal FBF response to fasudil and that to ACh (r=-0.67; P<0.01). There was no significant correlation between the maximal FBF response to fasudil and that to SNP. The intra-arterial coinfusion of fasudil significantly increased the FBF response to ACh in smokers but not in nonsmokers. There were no significant differences between FBF response to fasudil alone and that in combination with NG-monomethyl-L-arginine in smokers and in nonsmokers. The intra-arterial coinfusion ascorbic acid did not alter the FBF response to fasudil in both groups.
CONCLUSIONS: These findings suggest that smoking is involved in not only endothelial dysfunction but also activation of Rho-kinase in VSMCs in forearm circulation, and that there is a significant correlation between endothelial function and Rho-kinase activity in VSMCs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16210569     DOI: 10.1161/01.ATV.0000189304.32725.bd

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  22 in total

1.  Measurement of Rho-associated kinase (ROCK) activity in humans: validity of leukocyte p-MBS/t-MBS in comparison with vascular response to fasudil.

Authors:  Takaki Hata; Chikara Goto; Junko Soga; Takayuki Hidaka; Yuichi Fujii; Naomi Idei; Noritaka Fujimura; Tatsuya Maruhashi; Shinsuke Mikami; Yasuki Kihara; Kazuaki Chayama; Kensuke Noma; James K Liao; Yukihito Higashi
Journal:  Atherosclerosis       Date:  2010-10-12       Impact factor: 5.162

2.  Increased Rho kinase activity in a Taiwanese population with metabolic syndrome.

Authors:  Ping-Yen Liu; Jyh-Hong Chen; Li-Jen Lin; James K Liao
Journal:  J Am Coll Cardiol       Date:  2007-04-02       Impact factor: 24.094

3.  Exogenous nitric oxide inhibits Rho-associated kinase activity in patients with angina pectoris: a randomized controlled trial.

Authors:  Tatsuya Maruhashi; Kensuke Noma; Noritaka Fujimura; Masato Kajikawa; Takeshi Matsumoto; Takayuki Hidaka; Ayumu Nakashima; Yasuki Kihara; James K Liao; Yukihito Higashi
Journal:  Hypertens Res       Date:  2015-03-05       Impact factor: 3.872

4.  Impaired acetylcholine-induced cutaneous vasodilation in young smokers: roles of nitric oxide and prostanoids.

Authors:  Naoto Fujii; Maggie C Reinke; Vienna E Brunt; Christopher T Minson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-01-11       Impact factor: 4.733

5.  Cigarette smoke impairs clearance of apoptotic cells through oxidant-dependent activation of RhoA.

Authors:  Tiffany R Richens; Derek J Linderman; Sarah A Horstmann; Cherie Lambert; Yi-Qun Xiao; Robert L Keith; Darren M Boé; Konosuke Morimoto; Russell P Bowler; Brian J Day; William J Janssen; Peter M Henson; R William Vandivier
Journal:  Am J Respir Crit Care Med       Date:  2009-03-05       Impact factor: 21.405

Review 6.  Rho kinase: an important mediator of atherosclerosis and vascular disease.

Authors:  Qian Zhou; James K Liao
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

7.  A combination of increased Rho kinase activity and N-terminal pro-B-type natriuretic peptide predicts worse cardiovascular outcome in patients with acute coronary syndrome.

Authors:  Ming Dong; James K Liao; Bryan Yan; Ruijie Li; Mang Zhang; Cheuk-Man Yu
Journal:  Int J Cardiol       Date:  2012-08-24       Impact factor: 4.164

8.  Elevated rho-kinase activity as a marker indicating atherosclerosis and inflammation burden in polyvascular disease patients with concomitant coronary and peripheral arterial disease.

Authors:  Ming Dong; Xin Jiang; James K Liao; Bryan P Yan
Journal:  Clin Cardiol       Date:  2013-03-28       Impact factor: 2.882

9.  Cigarette smoke inhibits ROCK2 activation in T cells and modulates IL-22 production.

Authors:  Chien-Huan Weng; Sanjay Gupta; Patrick Geraghty; Robert Foronjy; Alessandra B Pernis
Journal:  Mol Immunol       Date:  2016-02-13       Impact factor: 4.407

10.  Increased Rho kinase activity in congestive heart failure.

Authors:  Ming Dong; James K Liao; Fang Fang; Alex Pui-Wai Lee; Bryan Ping-Yen Yan; Ming Liu; Cheuk-Man Yu
Journal:  Eur J Heart Fail       Date:  2012-05-15       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.